LisaMarieFrenkelMD
Pediatric Infectious Disease • Seattle, WAProfessor, Pediatrics, University of Washington School of Medicine
Dr. Frenkel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4800 Sand Point Way NE
Seattle, WA 98105Phone+1 206-987-2000
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Pediatrics, 1981 - 1987
University of Kansas School of MedicineClass of 1981
Certifications & Licensure
CA State Medical License 1982 - Present
WA State Medical License 1994 - 2025
NY State Medical License 1992 - 1994- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Clinical Trials
- A Pharmacokinetic and Tolerance Study of Oral Ganciclovir in HIV-Infected Children With Asymptomatic Cytomegalovirus Infection and Low CD4 Cell Counts or Quiescent Cytomegalovirus Disease
- A Study of Dideoxyinosine (ddI) in HIV-Infected Children Who Have Not Had Success With Zidovudine or Who Cannot Take Zidovudine
- Levels of Raltegravir in the Female Genital Tissue Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Characterizing HIV drug resistance in cases of vertical transmission in the VESTED randomized antiretroviral treatment trial.Marley D Bishop, Violet Korutaro, Ceejay L Boyce, Ingrid A Beck, Sheila M Styrchak
Journal of Acquired Immune Deficiency Syndromes. 2024-08-01 - Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir.Ingrid A Beck, Ceejay L Boyce, Marley D Bishop, Yen L Vu, Amanda Fung
Viruses. 2024-07-19 - Impact of Human Immunodeficiency Virus Drug Resistance Mutations Detected in Women Prior to Antiretroviral Therapy With Efavirenz + Tenofovir Disoproxil Fumarate + Lam...Ceejay L Boyce, Tatiana Sils, Ross S Milne, Jackson J Wallner, Samantha R Hardy
Open Forum Infectious Diseases. 2024-07-01
Press Mentions
- Seattle Children’s Researchers Discover That Functional COVID-19 Antibodies Are Lost Quickly After Mild CasesMay 27th, 2021
- Scientist Develops New Way to Test for COVID-19 AntibodiesOctober 23rd, 2020
CIDR to Merge with Seattle Children’s, Creating Largest Pediatric Infectious Disease Org in the USJuly 24th, 2018
Grant Support
- HIV-1 Evolution In The Female Genital Tract And Trafficking To The BloodNational Institute Of Allergy And Infectious Diseases2011–2012
- Academic Pediatric Infectious DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development2010–2012
- Viral Determinants Of HIV-1 Transmission In African HeterosexualsNational Institute Of Allergy And Infectious Diseases2010–2011
- HIV-1 Evolution In The Female Genital Tract And Trafficking To The BloodNational Institute Of Allergy And Infectious Diseases2010
- Quantification And Dynamics Of HIV-1 Drug Resistant Mutants By PirosequencingNational Institute Of Allergy And Infectious Diseases2009–2010
- Mechanism/Predictors Of Genital/Rectal HIV Shedding During ART W/Plasma <50c/MlNational Institute Of Allergy And Infectious Diseases2006–2010
- Reservoirs Of Drug-Resistant HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
- Pediatric LATE Outcomes (Aids Clinical Trial Group # 219)National Center For Research Resources2006–2007
- Pactg 1055: Psychiatric Co-Morbidity In Perinatally HIV -Infected ChildrenNational Center For Research Resources2006–2007
- Assessment Of Alveolar Macrophages As A Reservoir For HIVNational Center For Research Resources2005–2007
- Etiology Of Mastitis In HIV-1 Infected WomenNational Institute Of Allergy And Infectious Diseases2005–2006
- Immunization By HIV Exposure During ChemoprophylaxisEunice Kennedy Shriver National Institute Of Child Health &Human Development2001–2006
- Pediatric LATE Outcomes AIDS Clinical Trial Group # 219National Center For Research Resources2005
- Reservoirs Of Drug-Resistant HIV-1National Institute Of Allergy And Infectious Diseases2004
- Pediatric LATE Outcomes (Actg 219)National Center For Research Resources2004
- Prevention Of HIV Resistance To Nevirapine In PregnancyFogarty International Center2001–2003
- HIV Shedding And EvolutionEunice Kennedy Shriver National Institute Of Child Health &Human Development2002
- Pediatric LATE Outcome ProtocolNational Center For Research Resources2000–2002
- Therapy Effects On HIV 1 Population Dynamics In ChildrenEunice Kennedy Shriver National Institute Of Child Health &Human Development1998–2002
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–2002
- HIV 1 Dynamics &Resistance In Children Given Highly Active AntiretroNational Center For Research Resources1999–2000
- Phase II Evaluation On ZDV 3TC VS D4T Ritonavir VS ZDV 3TC RitonavirNational Center For Research Resources1998–2000
- Pediatric LATE Outcome Protocol--Actg219National Center For Research Resources1998–2000
- Immunizing By Mucosal SIV Exposure During RT InhibitionNational Center For Research Resources1998–1999
- A Study Of Hivig In Slowing Progression Of HIV Disease In HIV Infected ChildrenNational Center For Research Resources1997–1999
- Use Of Hivig For The Prevention Of Maternal-Fetal HIV TransmissionNational Center For Research Resources1996–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
